Expertise in
2
conditions

Dr. Benidecto Fernandez

Internal Medicine
Benidecto Fernandez MD P A
2140 W 68th St Ste 406, 
Hialeah, FL 
44 Years of Experience
Expertise in
2
conditions
Benidecto Fernandez MD P A
2140 W 68th St Ste 406, 
Hialeah, FL 

Overview

Benidecto Fernandez is an Internal Medicine provider practicing medicine in Hialeah, Florida. He has been practicing medicine for over 44 years.

Dr. Fernandez is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Fibromyalgia, Palindromic Rheumatism, and Postmenopausal Osteoporosis.

He is actively involved in clinical research, participating in 6 clinical trials.

Graduate Year

1982

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Benidecto Fernandez MD P A
2140 W 68th St Ste 406, Hialeah, FL 33016

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
7
conditions
Dr. Aman Chauhan
Internal Medicine
Expertise in
7
conditions
Dr. Aman Chauhan
Internal Medicine

Umhc-Sylvester Comprehensive Cancer Center

1475 NW 12th Ave, 
Miami, FL 
 (9.6 miles away)
859-257-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Aman Chauhan is an Internal Medicine provider practicing medicine in Miami, Florida. Dr. Chauhan is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Merkel Cell Carcinoma, Small Cell Lung Cancer (SCLC), Vaginectomy, and Embolectomy.

Expertise in
50
conditions
Dr. Jose Contreras
Internal Medicine
Expertise in
50
conditions
Dr. Jose Contreras
Internal Medicine

Helping Hands Ppec Inc.

7100 W 20th Ave Ste G126, 
Hialeah, FL 
 (1.0 miles away)
305-882-7747
Languages Spoken:
English
See accepted insurances

Jose Contreras is a primary care provider, practicing in Internal Medicine in Hialeah, Florida. Dr. Contreras is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Necrosis, Hypertensive Heart Disease, Enlarged Liver, Prostatectomy, and Gastrostomy.

Expertise in
13
conditions
Dr. Leonard Hoenig
Internal Medicine
Expertise in
13
conditions
Dr. Leonard Hoenig
Internal Medicine

Office

601 N Flamingo Rd Ste 201, 
Pembroke Pines, FL 
 (9.6 miles away)
954-438-0077
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leonard Hoenig is a primary care provider, practicing in Internal Medicine in Pembroke Pines, Florida. Dr. Hoenig is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Hartnup Disease, Rhinophyma, Smallpox, and Buschke-Ollendorff Syndrome.

Frequently Asked Questions about Dr. Benidecto Fernandez

How do I make an appointment with Dr. Benidecto Fernandez?

You can book an appointment with Dr. Benidecto Fernandez by calling their office at 305-362-4979. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Benidecto Fernandez a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benidecto Fernandez is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Benidecto Fernandez specialize in?

While Dr. Benidecto Fernandez is a Internal Medicine, they have specific expertise in Rheumatoid Arthritis (RA), Fibromyalgia, and Palindromic Rheumatism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Benidecto Fernandez accept my insurance?

Dr. Benidecto Fernandez accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-362-4979 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fernandez's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile